Altered NHLRC2 protein and gene expression levels have been detected in neurodegenerative diseases such as Parkinson (35) and Alzheimer’s disease (36); however, publications on the role of NHLRC2 in MS are still lacking. This evidence concerns the gene NHLRC2 and early-onset autosomal dominant Alzheimer disease.